The Importance of FAIR Data and Processes
Data and Process Driven R&D Organizations Need to Transform
Search Results
The Evolving Landscape of PROTAC® Technology: Implications for Small Molecule and Multimodal Drug Discovery
PROTAC technology and TPD research present many opportunities in drug discovery. Learn how Signals One provides a comprehensive R&D workflow.
Today's Lab Problem, Tomorrow's Solution: Integrating Benchtop Devices with Signals Digital Lab Exchange (DLX) powered by Scitara
Signals DLX can integrate any lab instrument or application with Signals Notebook. Learn how this provides more time for science, improves workflow and ends manual data entry.
Nexus 2021 Day One Recap: Cutting-Edge Solutions Redefining Research & Clinical Informatics
Nexus 2021 – Revvity Signals Virtual User Conference – kicked off today with an exciting schedule of keynotes, technology innovation spotlights, and industry case studies from companies including Merck, Janssen, Roche Diagnostics, Bayer, Gilead Science, Bristol Meyer Squibb, and more.
From Data Overload to Insight: Using AI and ML for Security Trend Prediction
Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals uses AI and other techniques to protect data.
Why Cloud Matters in Scientific R&D
Revvity Signals handles all software development, allowing researchers to explore new drug therapies. Learn how our cloud-native software helps with performance, cost and scalability.
Revvity Signals 2024: Empowering Scientific Innovation and Collaboration
In 2024, Signals ChemDraw, Signals Clinical and Signals Synergy launched. Read how Revvity Signals supports new modalities in drug discovery and research development.
Nexus 2021 Day Two Recap: Empowering Data-Driven Science with Flexible Informatics
Nexus 2021 Day Two Recap: Empowering Data-Driven Science with Flexible Informatics Day Two of Revvity Signal's Nexus 2021 Informatics Virtual User Conference delivered another engaging slate of presenters – from Merck KGaA, Birla Carbon and Givaudan to Bayer, Nimbus Therapeutics and Johnson & Johnson. If you’ve registered but missed a session (or even a day...